A metabolic biomarker predicts Parkinson’s disease at the early stages in patients and animal models

BACKGROUND: Care management of Parkinson’s disease (PD) patients currently remains symptomatic, mainly because diagnosis relying on the expression of the cardinal motor symptoms is made too late. Earlier detection of PD therefore represents a key step for developing therapies able to delay or slow d...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallet, David, Dufourd, Thibault, Decourt, Mélina, Carcenac, Carole, Bossù, Paola, Verlin, Laure, Fernagut, Pierre-Olivier, Benoit-Marand, Marianne, Spalletta, Gianfranco, Barbier, Emmanuel L., Carnicella, Sebastien, Sgambato, Véronique, Fauvelle, Florence, Boulet, Sabrina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843749/
https://www.ncbi.nlm.nih.gov/pubmed/34914634
http://dx.doi.org/10.1172/JCI146400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843749/
https://www.ncbi.nlm.nih.gov/pubmed/34914634
http://dx.doi.org/10.1172/JCI146400

Ejemplares similares